SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15510047

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods for treating or preventing prediabetes or diabetes, or maintaining or lowering blood or plasma glucose or maintaining or lowering blood or plasma glycated hemoglobin comprising administering to a subject in need thereof a therapeutically effective amount of a compound selectively inhibiting NaV1.7. In particular, provided herein are processes for the preparation of and intermediates used in the preparation of compounds selectively inhibiting NaV 1.7, such as the compounds of Formula I or compounds of Formula I′:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHROMOCELL CORPORATIONNORTH BRUNSWICK NJ

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BABICH, Olga Cranford, US 4 6
GARYANTES, Tina Warren, US 12 167
LUO, Robert Z New City, US 6 6
Venkatachalan, Srinivasan P Monmouth Junction, US 6 15
WANG-FISCHER, Yanlin Hillsborough, US 4 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation